EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma
Clinical trial NCT02664363 · TERMINATED
Trial details
- NCT number
- NCT02664363
- Sponsor
- Daniel Landi
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-01
- Primary completion
- 2018-09-25
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.